Gregory Lee Durst - Indianapolis IN, US Bryan Hurst Norman - Indianapolis IN, US Lance Allen Pfeifer - Indianapolis IN, US Timothy Ivo Richardson - Indianapolis IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D 311/76 C07D 311/94
US Classification:
514454, 549385, 549390
Abstract:
The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof and processes for the preparation of the same. The compounds of the present invention are useful as Estrogen Receptor ? agonists. Such agonists are useful for the treating Estrogen Receptor ? mediated diseases such as prostate cancer or BPH.
Substituted Benzopyrans As Selective Estrogen Receptor-Beta Agonists
Gregory Lee Durst - Indianapolis IN, US Bryan Hurst Norman - Indianapolis IN, US Timothy Ivo Richardson - Indianapolis IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D 311/78 A01N 43/16
US Classification:
549385, 514454
Abstract:
The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof useful as Estrogen Receptor β agonists for treating Estrogen Receptor β mediated diseases such as benign prostatic hyperplasia.
Substituted Benzopyrans As Selective Estrogen Receptor-Beta Agonists
Gregory Lee Durst - Indianapolis IN, US Bryan Hurst Norman - Indianapolis IN, US Timothy Ivo Richardson - Indianapolis IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D 409/00 C07D 311/78 A61K 31/38 A61K 31/35
US Classification:
549 46, 549385, 514443, 514454
Abstract:
The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof useful as Estrogen Receptor beta agonists for treating Estrogen Receptor beta mediated diseases such as benign prostatic hyperplasia.
Substituted Benzopyrans As Selective Estrogen Receptor-Beta Agonists
Gregory Lee Durst - Indianapolis IN, US Bryan Hurst Norman - Indianapolis IN, US Lance Allen Pfeifer - Indianapolis IN, US Timothy Ivo Richardson - Indianapolis IN, US
The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof useful as Estrogen Receptor beta agonists for treating Estrogen Receptor beta mediated diseases such as benign prostatic hyperplasia.
Fungicidal Compositions And Methods, And Compounds And Methods For The Preparation Thereof
John L. Miesel - Indianapolis IN Zoltan L. Benko - Indianapolis IN William H. Dent - Indianapolis IN Gregory L. Durst - Indianapolis IN Gina M. Fitzpatrick - Westfield IN David D. Johnson - Greenfield IN Sylvester V. Kaster - Indianapolis IN Gregory M. Kemmitt - Lafayette IN William C. Lo - Indianapolis IN Marc J. McKennon - Issaquah WA Ann B. Orth - Langhorne PA Michael J. Ricks - Indianapolis IN Richard B. Rogers - Zionsville IN Todd L. Werk - Indianapolis IN
Assignee:
Dow AgroSciences LLC - Indianapolis IN
International Classification:
C07C23374 A01N 3744
US Classification:
564166
Abstract:
Fungicidal compositions and methods comprising acylated aminosalicylamides (AASA) described herein. Novel cyclic amines and 3-nitrosalicylamides, and their use as pesticides and in the preparation of the antifungal AASA compounds are also disclosed.